The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- Up 5% in early trading this morning, Spectrum Pharmaceuticals (NASDAQ:SPPI) is seeing action on sales growth expectations of its colon cancer drug Fusilev. According to … Continue Reading
Read now- Bristol-Myers Squibb (NYSE:BMY) reported its second quarter results this morning, with an 18% loss in revenue from last year to $4.44B, and net income of … Continue Reading
Read nowResearch - Regulatory changes are about to impose significant pressures upon the growth of a major medical equipment manufacturer – to the tune of 30% or more.
Read now- BioCryst Pharmaceuticals (NASDAQ:BCRX) announced this morning that its Phase 2b trial of ulodesine, in tandem with allopurinol, had favorable safety and sustained efficacy in extended … Continue Reading
Read now- The results of Amarin’s (NASDAQ:AMRN) pivotal ANCHOR Phase 3 clinical trial are now available electronically through The American Journal of Cardiology and are scheduled for … Continue Reading
Read now- Zogenix (NASDAQ:ZGNX) has officially priced its announced stock offering at $2.00/unit, each unit consisting of one share of common stock and one warrant to purchase … Continue Reading
Read now- The laboratory analytical products company (NYSE:WAT) reported second quarter adjusted EPS of $1.17, above Wall Street’s Consensus estimate of $1.16. However, WAT missed revenue estimates, … Continue Reading
Read now
